ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.

Comparing 3 Schedules of Alimta Plus Gemzar

NCT00034606 ·Status: COMPLETED ·Phase: PHASE2

Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer

NCT00259285 ·Status: TERMINATED ·Phase: PHASE2

Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.

NCT00061464 ·Status: COMPLETED ·Phase: PHASE2

Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy

NCT00630149 ·Status: COMPLETED ·Phase: PHASE2

A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma

NCT00192088 ·Status: COMPLETED ·Phase: PHASE2

Alimta and Gemcitabine in Non-Small Cell Lung Cancer

NCT00434135 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.

NCT00034619 ·Status: COMPLETED ·Phase: PHASE2

A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer

NCT00078260 ·Status: COMPLETED ·Phase: PHASE3

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial

NCT00061451 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium

NCT00035061 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma

NCT00190801 ·Status: COMPLETED ·Phase: PHASE2

Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma

NCT00087698 ·Status: COMPLETED ·Phase: PHASE2

Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma

NCT00895648 ·Status: TERMINATED ·Phase: PHASE2

Pemetrexed Plus Cisplatin Bi-Weekly, in Patients With Urothelial Cancer (Metastatic, Locally Advanced or Non-Resectable)

NCT00374868 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC

NCT00517595 ·Status: COMPLETED ·Phase: PHASE2

Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate

NCT00165503 ·Status: TERMINATED ·Phase: PHASE2

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma

NCT00061477 ·Status: COMPLETED ·Phase: PHASE2

Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer

NCT00365183 ·Status: TERMINATED ·Phase: PHASE2

A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

NCT00034593 ·Status: COMPLETED ·Phase: PHASE2

A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer

NCT01017874 ·Status: COMPLETED ·Phase: PHASE3

Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy

NCT00489983 ·Status: COMPLETED ·Phase: PHASE2

A Study for Patients With Head and Neck Cancer

NCT00415194 ·Status: COMPLETED ·Phase: PHASE3

A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer

NCT01165021 ·Status: COMPLETED ·Phase: PHASE2

A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma

NCT00794417 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy

NCT00343720 ·Status: COMPLETED ·Phase: PHASE2